CROFAB: payments to doctors
Payments that named CROFAB as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.7M
- Providers
- 787
- Transactions
- 2,049
- Average per transaction
- $850
The per-transaction average — $850 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 787 providers the average total is $2,213, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| BTG International, Inc. | $1,636,827 | 94.0% |
| BTG International Inc. | $99,553 | 5.7% |
| Biocompatibles, Inc. | $5,527 | 0.3% |